Anticoagulation with low-molecular-weight heparin dalteparin in atrial fibrillation

被引：0
|
作者：
Bechtold, H
Sawitzki, H
Gunzenhauser, D
Janssen, D
机构：
[1] Kreiskrankenhaus, Innere Abt, Crailsheim, Germany
[2] Pharmacia & Upjohn Inc, Erlangen, Germany
来源：
EUROPEAN HEART JOURNAL | 2000年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
158
引用
收藏
页码：8 / 8
页数：1
相关论文
共 50 条
  • [1] Anticoagulation with the low-molecular-weight heparin dalteparin (Fragmin®) in atrial fibrillation and TEE-guided cardioversion
    Bechtold, H
    Gunzenhauser, D
    Sawitzki, H
    Fung, S
    Janssen, D
    ZEITSCHRIFT FUR KARDIOLOGIE, 2003, 92 (07): : 532 - 539
  • [2] Dalteparin: A low-molecular-weight heparin
    Howard, PA
    ANNALS OF PHARMACOTHERAPY, 1997, 31 (02) : 192 - 203
  • [3] Anticoagulation After Stroke in Patients With Atrial Fibrillation: To Bridge or Not With Low-Molecular-Weight Heparin?
    Altavilla, Riccardo
    Caso, Valeria
    Bandini, Fabio
    Agnelli, Giancarlo
    Tsivgoulis, Georgios
    Yaghi, Shadi
    Furie, Karen L.
    Tadi, Prasanna
    Becattini, Cecilia
    Zedde, Marialuisa
    Abdul-Rahim, Azmil H.
    Lees, Kennedy R.
    Alberti, Andrea
    Venti, Michele
    Acciarresi, Monica
    D'Amore, Cataldo
    Mosconi, Maria Giulia
    Cimini, Ludovica Anna
    Fusaro, Jessica
    Bovi, Paolo
    Carletti, Monica
    Rigatelli, Alberto
    Cappellari, Manuel
    Putaala, Jukka
    Tomppo, Liisa
    Tatlisumak, Turgut
    Marcheselli, Simona
    Pezzini, Alessandro
    Poli, Loris
    Padovani, Alessandro
    Masotti, Luca
    Vannucchi, Vieri
    Sohn, Sung-Il
    Lorenzini, Gianni
    Tassi, Rossana
    Guideri, Francesca
    Acampa, Maurizio
    Martini, Giuseppe
    Ntaios, George
    Athanasakis, George
    Makaritsis, Konstantinos
    Karagkiozi, Efstathia
    Vadikolias, Konstantinos
    Liantinioti, Chrysoula
    Chondrogianni, Maria
    Mumoli, Nicola
    Consoli, Domenico
    Galati, Franco
    Sacco, Simona
    Carolei, Antonio
    STROKE, 2019, 50 (08) : 2093 - 2100
  • [4] Anticoagulation with low-molecular-weight heparin (dalteparin) in plasmapheresis therapy: initial experience
    Schinzel, H
    Berghoff, K
    Beuermann, I
    Sauer, O
    von Mach, MA
    Weilemann, LS
    TRANSFUSION, 2006, 46 (04) : 624 - 629
  • [5] Atrial fibrillation: Is there a role for low-molecular-weight heparin?
    Camm, AJ
    CLINICAL CARDIOLOGY, 2001, 24 (03) : I15 - I19
  • [6] Low-molecular-weight heparin as bridging anticoagulation
    van Dongen, CJ
    Vink, R
    Levi, M
    ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (22) : 2500 - 2500
  • [7] Low-molecular-weight heparin (dalteparin) in women with gynecologic malignancy
    DeBernardo, RL
    Perkins, RB
    Littell, RD
    Krasner, CN
    Duska, LR
    OBSTETRICS AND GYNECOLOGY, 2005, 105 (05): : 1006 - 1011
  • [8] Anticoagulation with the low-molecular-weight heparin dalteparin (Fragmin®) in atrial fibrillation and TEE-guided cardioversionAntikoagulation mit dem niedermolekularen Heparin Dalteparin (Fragmin®) bei Vorhofflimmern und TEE-geführter Kardioversion
    H. Bechtold
    D. Gunzenhauser
    H. Sawitzki
    S. Fung
    D. Janssen
    Zeitschrift für Kardiologie, 2003, 92 : 532 - 539
  • [9] In vitro anticoagulation monitoring of low-molecular-weight heparin
    WANG JianqiSHI XuboYANG Jingang and HU Dayi Department of Cardiovascular CenterBeijing Tongren HospitalAffiliated to Capital Medical UniversityBeijing China Department of CardiologyCardiovascular Institute Fu WaiHospitalChinese Academy of Medical Sciences Peking UnionMedical CollegeBeijing China Department of CardiologyPeking University Peoples HospitalBeijing China
    中华医学杂志（英文版）, 2009, (10) : 1199 - 1202
  • [10] In vitro anticoagulation monitoring of low-molecular-weight heparin
    Wang Jian-qi
    Shi Xu-bo
    Yang Jin-gang
    Hu Da-yi
    CHINESE MEDICAL JOURNAL, 2009, 122 (10) : 1199 - 1202
12345